Tag Archives: Alzheimer’s Disease International (ADI)

The State of Dementia Research Globally: World Alzheimer Report 2018 (Alzheimer’s Disease International)

Posted on March 2, 2019 by Dementia and Elderly Care News

Summary The World Alzheimer Report 2018, entitled “The state of the art of dementia research: New frontiers”, reviews developments in dementia research, without glossing-over the absence of significant disease-modifying pharmacological treatment breakthroughs for around 20 years. This report examines wide-ranging … Continue reading →

Posted in Acute Hospitals, Alzheimer’s Disease International (ADI), Charitable Bodies, Community Care, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Mental Health, Models of Dementia Care, Person-Centred Care, Quick Insights, Standards, Statistics, UK, Universal Interest | Tagged ADI’s World Alzheimer Reports, Alireza Atri: Director of Banner Sun Health Research Institute, Alzheimer's Research, Alzheimer’s Disease International (ADI), Alzheimer’s Disease Research Unit: McGill Centre for Studies in Ageing (Canada), Alzheimer’s Prevention Initiative: Banner Health (USA), Alzheimer’s Prevention Initiative: Banner Sun Health Research Institute, Banner Sun Health Research Institute, Burden of Alzheimer’s Disease, Burden of Dementia (Statistics), Centre for Dementia Prevention: University of Edinburgh, Dementia as Cause of Death, Dementia Awareness, Dementia Awareness Raising, Dementia Collaborative Research Centre: University of New South Wales, Dementia Discovery Fund, Dementia Discovery Fund (DDF), Dementia Prevention, Dementia Research, Dementia Research Funding, Dementia Research Priorities, Dementia Risk Reduction, Dementia Risk Reduction and Prevention, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies for Dementia, Disease-Modifying Treatments for Dementia, Dr Christopher Chen: Director of Memory Ageing and Cognition Centre at National University Health System: Singapore, Dr Doug Brown: Chief Executive Officer of British Society for Immunology, Dr Doug Brown: Former Chief Policy and Research Officer at Alzheimer’s Society, Dr Jennifer Bute: Dementia Alliance International (DAI), Dr Kenji Toba: President of National Centre for Geriatrics and Gerontology (Obu), Dr Maria Carrillo: Chief Science Officer at Alzheimer’s Association US, Dr Miia Kivipelto: Karolinska Institute, Dr Miia Kivipelto: Karolinska University Hospital (Stockholm), Dr Rachelle Doody: Global Head of Neurodegeneration at Roche, Dr Serge Gauthier: Director of Alzheimer’s Disease Research Unit at McGill Centre for Studies in Ageing in Canada, Drug Trials Failure Rate, Epidemiology, Epidemiology and Statistics, Francesca Colombo: Organisation for Economic Co-operation and Development (OECD), Fundación para la Lucha contra las Enfermedades Neurológicas (FLENI), Glenn Rees: Chairman of Alzheimer’s Disease International, Glenn Rees: Former CEO of Alzheimer’s Australia, Global Burden of Dementia, Global Dementia Discovery Fund (2015), Identification and Intervention for Dementia in Elderly Africans (IDEA Group), Jeff Cummings: Director of Cleveland Clinic at Lou Ruvo Centre for Brain Health, Kate Bingham: SV Health Managers, King’s College London, Market Failure (Dementia Research and Drug Development), Martin Knapp: London School of Economics, Memory Ageing and Cognition Centre at National University Health System: Singapore, Memory Ageing and Cognition Centre: National University Health System (Singapore), National Centre for Geriatrics and Gerontology (Japan), Optima (University of Oxford’s Dementia Research Project), OPTIMA Cohort (Oxford Project to Investigate Memory and Ageing), Oxford Project to Investigate Memory and Ageing (OPTIMA Study), Paola Barbarino: Alzheimer’s Disease International, Prevention, Prevention Agenda, Prevention of Future Dementia Cases by Increasing Knowledge of Risk and Protective Factors, Professor Adesola Ogunniyi: University College Hospital (Ibadan), Professor Bart De Strooper: Director of the UK Dementia Research Institute (UK DRI), Professor Craig Ritchie: Chair of Psychiatry of Ageing at University of Edinburgh, Professor Craig Ritchie: Director at Centre for Dementia Prevention, Professor Gordon Wilcock: Co-founder of Alzheimer’s Society UK, Professor Gordon Wilcock: Emeritus Professor of Geratology at University of Oxford, Professor Henry Brodaty: Director of Dementia Collaborative Research Centre at University of New South Wales, Professor Martin Knapp: Director of the Personal Social Services Research Unit at the London School of Economics and Political Science (LSE), Professor Martin Prince: Assistant Principal for Global Health at King’s College London, Research Networks, Ricardo Allegri: Head of Cognitive Neurology Neuropsychology and Neuropsychiatry at Fundación para la Lucha contra las Enfermedades Neurológicas (FLENI), Risk and Protective Factors, State of the Art of Dementia Research: New Frontiers (World Alzheimer Report 2018), Supporting People Affected by Dementia, UK Dementia Research Institute, UK Dementia Research Institute (UK DRI), UK Dementia Research Institute at UCL, University College Hospital (Ibadan Nigeria), World Alzheimer Report, World Alzheimer Report 2018: State of the Art of Dementia Research, World Alzheimer Report: 2018, World Alzheimer’s Day 2018 | Leave a comment

Dementia Medication De-Listed in France: Untruth, Half-Truth or Paternalistic News Blackout? (BBC News / Prescrire / ADI / Inside Health / JAMA Network Open)

Posted on October 18, 2018 by Dementia and Elderly Care News

Summary Early evening headlines yesterday, on BBC Radio 4 news, announced the “shocking” news that drugs for Alzheimer’s Disease / dementia had been de-listed in France. This story has not been followed-up, and appears to have been dropped quietly; although … Continue reading →

Posted in Alzheimer’s Disease International (ADI), Universal Interest | Tagged Adverse Drug Reactions, Adverse Effects, Alpha-7 Nicotinic Acetylcholine Receptor (α7nAChR), Alzheimer's Disease: Monotherapy Versus Combination Therapy, Alzheimer's Research and Therapy, Alzheimer’s Disease International (ADI), Alzheimer’s Disease International (ADI) Campaigns, American Family Physician, Anti-Dementia Medication, Augusta University, BBC Radio 4, BBC Radio 4's Inside Health Programme, BBC Radio 4’s PM Programme, Big Pharma, BMJ, BMJ Publishing Group Ltd, British Medical Journal (BMJ), Cambridge Institute of Public Health: University of Cambridge, Care of the Elderly Medicine Department: Royal Wolverhampton NHS Trust, Cholinergic-Nicotinic System, Choosing Wisely, Clinic for Medicine of the Elderly (Hannover), Conflict of Interests, Conflicts of Interest, Department of Behavioral Neuroscience and Drug Development: Polish Academy of Sciences, Department of Psychiatry and Behavioral Health: Marshfield Clinic Health System, Department of Psychiatry and Behavioral Sciences: George Washington University School of Medicine and Health Sciences, Department of Psychiatry and Health Behavior: Augusta University, Department of Public Health and Primary Care: University of Cambridge, Deprescribing, Donepezil, Donepezil-Memantine Combination, Donepezil-Memantine: Monotherapy Versus Combination Therapy, Drug Efficacy, Drug Side-Effects, Drugs Alleged to Raise False Hopes (Speculative Construct), Family Medicine Residency Program: Southern Illinois University School of Medicine, Family Physicians Inquiries Network (FPIN), Formindep: Non-Profit Organisation Promoting Independence From Industry Influence, France, France's National Authority for Health (HAS), French Ministry of Health and Solidarity, French National Dementia Guidelines, Galantamine, Galantamine-Memantine Combination Versus Donepezil-Memantine Combination, Galantamine-Memantine Drug Combination, George Washington University School of Medicine and Health Sciences, Germany, Glutamatergic Receptor Systems, Glutamatergic System, Harms of Too Much Medicine, Institute of Pharmacology: Polish Academy of Sciences, JAMA Network Open, Janssen Research and Development, Journal of Geriatric Care and Research (JGCR), Keck School of Medicine: University of Southern California, KYNA/3-HK, KYNA/KYN, KYNA/QUIN, Kynurenic Acid, Kynurenine Pathway, Marshfield Clinic Health System (USA), Medical College of Georgia: Augusta University, Memantine, Ministry of Health and Solidarity (France), Mismatch Negativity (MMN), Mount Sinai Medical Center (New York), National Institutes of Health (NIH), National Institutes of Health (US), Neurotransmitter Systems in Alzheimer’s Disease, New Cross Hospital, New Cross Hospital: Royal Wolverhampton NHS Trust, NMDA (N-Methyl-D-Aspartate), Over-Treatment, Oxidative Stress, Paola Barbarino: Alzheimer’s Disease International, Poland, Polish Academy of Sciences, Prescrire in English [the Prescriber] / Rev. Prescrire, Reducing Waste in Dementia Care, Reducing Waste in the NHS, Rivastigmine, Royal Wolverhampton NHS Trust, Serge Gauthier: ADI’s Medical and Scientific Advisory Panel (MSAP), Society of Biological Psychiatry (SOBP), Southern Illinois University, Southern Illinois University School of Medicine, Synaptec Inc (Florida), Too Much Medicine, United States, University of Alabama at Birmingham, University of Cambridge, University of Southern California, USA | Leave a comment

Healthcare Pathways For People Living With Dementia: World Alzheimer Report 2016 (Alzheimer’s Disease International)

Posted on October 6, 2016 by Dementia and Elderly Care News

Summary The World Alzheimer Report 2016, entitled “Improving healthcare for people living with dementia” reviews evidence on aspects of healthcare for people with dementia and suggests how improvements and efficiency savings can be made. The authors are against over-specialization of … Continue reading →

Posted in Acute Hospitals, Alzheimer’s Disease International (ADI), Charitable Bodies, Commissioning, Community Care, Diagnosis, End of Life Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, International, Management of Condition, Mental Health, Models of Dementia Care, Non-Pharmacological Treatments, Patient Care Pathway, Person-Centred Care, Quick Insights, Standards, Statistics, Systematic Reviews, UK, Universal Interest | Tagged 10/66 Dementia Research Group, Access to Palliative Care, ADI’s World Alzheimer Reports, Advance Care Planning (ACP), Ageing Population, Ageing Society, Alzheimer’s Disease International (ADI), Alzheimer’s Disease International’s 10/66 Dementia Research Group, Benefits of Case Management, Better Policies for People with Dementia, Canada, Canadian Centre for Family Medicine Family Health Team (CCFM-FHT) Ontario Memory Clinic, Canadian Comfort Care Booklet, Canadian Comfort Care Principles, Canadian Mild Dementia Knowledge Transfer Toolkit, Care Coordination / Case Management Approaches For People With Dementia Living at Home, Care Coordination and Navigation, Case Management for Dementia, Challenges of Living with Dementia, China, Clinical Practice Guidelines and Care Pathways for People with Dementia Living in the Community (Queensland University of Technology), Community Care, Community Care Services, Community-Based Care, Community-Based Care for People With Dementia, Cost Implications of Dementia Healthcare Pathways, Counter-Factual Service Modelling, Dedicated Care Coordination, Dementia Care in Acute General Hospitals, Dementia Care Pathways, Dementia Healthcare Pathways, Dementia Post-Diagnostic Care and Support, Dementia Research Priorities For Healthcare Sector (WHO Research Prioritization Exercise), Dementia Risk Reduction, Dementia Risk Reduction and Prevention, Dementia: Prevalence and Detection, Early Detection of Alzheimer’s Disease, European Association for Palliative Care White Paper, Global Action Against Dementia, Global Burden of Dementia, Global Context, Global Costs of Dementia, Global Dementia Crisis, Global Dementia Crisis: Adaptations to Services, Global Dementia Crisis: Re-Balancing of Funding For Services, Global Dementia Crisis: Re-Balancing of Services, Global Health, Global Observatory for Ageing and Dementia Care, Global Observatory for Ageing and Dementia Care: King’s College London, Global Outlook, Health Service and Population Research Department: King’s College London, Improving Healthcare For People Living With Dementia: World Alzheimer Report 2016, Improving Outcomes for People Living With Dementia, Indonesia, Integrated and Community-Based Care, Integration of Primary Secondary and Community Care, King’s College London, Living with Dementia, London School of Economics and Political Science (LSE), LSE's Personal Social Services Research Unit (PSSRU), Managing Comorbidity and Complexity, Mexico, Palliative Care, Personal Social Services Research Unit (PSSRU), Personal Social Services Research Unit (PSSRU): London School of Economics and Political Science, Primary Care, Professor Martin Knapp: Director of the Personal Social Services Research Unit at the London School of Economics and Political Science (LSE), PSSRU at London School of Economics and Political Science, Queensland University of Technology Clinical Practice Guidelines and Care Pathways for People with Dementia Living in the Community, South Africa, South Korea, Switzerland, Systematic Reviews and Meta-Analyses, Task-Sharing, Task-Shifting, Typical Duration of Care Inputs Across the Care Pathway, Typical Intensity / Frequency of Care Inputs Across the Care Pathway, World Alzheimer Report 2016, World Health Organization Mental Health Gap Action Programme (mhGAP) Evidence Based Guidelines | Leave a comment

Global Impact of Dementia: World Alzheimer Report 2015 (Alzheimer’s Disease International)

Posted on August 27, 2015 by Dementia and Elderly Care News

Summary The World Alzheimer Report 2015, entitled “The Global Impact of Dementia: An analysis of prevalence, incidence, cost and trends” updates Alzheimer’s Disease International (ADI)’s global dementia statistics. This document reviews and analyses previous systematic reviews on the subject, and … Continue reading →

Posted in Alzheimer’s Disease International (ADI), Charitable Bodies, Commissioning, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, International, Management of Condition, Models of Dementia Care, Quick Insights, Standards, Statistics, Systematic Reviews, UK, Universal Interest | Tagged ADI’s World Alzheimer Reports, Ageing Population, Ageing Society, Alzheimer’s Disease International (ADI), Cambridge Institute of Public Health, Cambridge Institute of Public Health: Cambridge University, Cambridge Institute of Public Health: University of Cambridge, Centre for Global Health Research: University of Edinburgh Medical School, Dementia Policy, Department of Neurobiology Care Sciences and Society: Karolinska Institutet, Epidemiology, Epidemiology and Statistics, First Global Ministerial Conference on Global Action Against Dementia, First Ministerial Conference on Global Action Against Dementia, First WHO Ministerial Conference on Global Action Against Dementia, First WHO Ministerial Conference on Global Action Against Dementia: Better Policies for People with Dementia, Global Action Against Dementia, Global Burden of Dementia, Global Context, Global Costs of Dementia, Global Dementia Framework, Global Health, Global Impact of Dementia: World Alzheimer Report 2015, Global Incidence of Dementia, Global Leadership, Global Ministerial Conference on Global Action Against Dementia (WHO), Global Observatory for Ageing and Dementia Care, Global Observatory for Ageing and Dementia Care: King’s College London, Global Outlook, Global Prevalence of Dementia, Global Social Investment for Dementia, Incidence Studies, Joint Action on Dementia, Karolinska Institute, Karolinska Institutet (Stockholm), Kings College London, Ministerial Conference on Global Action, Nossal Institute for Global Health: University of Melbourne, Peking University Health Science Center, Prevalence, Prevalence of Dementia, School of Public Health: Peking University Health Science Center, Systematic Reviews and Meta-Analyses, University of Cambridge, University of Edinburgh Medical School, University of Melbourne, World Alzheimer Report, World Alzheimer Report 2015, World Health Organization (WHO), World Health Organization’s First Ministerial Conference on Global Action Against Dementia, Worldwide Costs of Dementia | Leave a comment

Dementia Care, Patient Experience and Risk Reduction Are Priorities for World Dementia Council (Department of Health / Dementia Challenge / WDC)

Posted on November 30, 2014 by Dementia and Elderly Care News

Summary It has been agreed at the World Dementia Council‘s third meeting in London (held at the Foreign and Commonwealth Office on Friday October 17th 2014) that dementia care (i.e. health and social care) and risk reduction should be added … Continue reading →

Posted in Alzheimer’s Disease International (ADI), Charitable Bodies, Commissioning, Community Care, Department of Health, Diagnosis, End of Life Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, Integrated Care, International, Management of Condition, Mental Health, Models of Dementia Care, National, NIHR, Non-Pharmacological Treatments, Person-Centred Care, Pharmacological Treatments, Quick Insights, Standards, UK, Universal Interest, World Health Organization (WHO) | Tagged Achieving Dementia Friendly Acute care, Alzheimer's Research UK, Alzheimer’s Disease International (ADI), Behavioural Risk Factors, Behavioural Risk Factors and Dementia, Challenge on Dementia (David Cameron), Collaborative Projects, Community Rehabilitation, Continuity Plans (WDC and GAAD Agenda), Conversion to Dementia From Prodromal Disease, Cross-Sector Partnerships, Danish Health and Medicines Authority, Dementia Alliance International, Dementia Awareness, Dementia Challenge, Dementia Risk Factors, Dennis Gillings: Former World Dementia Envoy, Department of Health Dementia Challenge, Department of Health's Digital Health Blog, Digital Engagement, Dr Kiyoshi Kurokawa: Professor of the National Graduate Institute for Policy Studies and Science Advisor to the Cabinet of Japan, Dr Margaret Chan: WHO Director-General, European Medicines Agency, Experiences, Experiences of Diagnosis, Experts by Experience, F ederal Institute for Drugs and Medical Devices Germany, Finance and Incentives, Fourth World Dementia Council Meeting (February 2015), G7 Countries, G7 Global Dementia Summit, G8 Dementia Summit, GADAA Toolkit: Global Alzheimer’s and Dementia Action Alliance, Geoff Huggins: Scottish Government, Global Action Against Dementia, Global Alzheimer’s and Dementia Action Alliance (GADAA), Global Envoy for Dementia Innovation, Global Leadership, Global Outlook, Global Social Investment for Dementia, Harry Johns: President and CEO of Alzheimer’s Association, Harry Johns: World Dementia Council Member, Health Canada, Healthy Behaviours, Healthy Communities, Healthy Lifestyles, Hilary Doxford: World Dementia Council Member, Innovation in Care and Prevention (Japan Legacy Event), Innovative Technology, Integrated Development, International Collaborations, International Dementia Research Inventories, International Programmes, Italian Medicines Agency, Japan Legacy Event, Japan Legacy Event: Innovation in Care and Prevention, Japan’s G7 Legacy Event on Dementia Care and Prevention, JP Morgan, Kate Swaffer: Chair of Dementia Alliance International, Legacy Event in March 2015, Lifestyle Risk Factors, Lived Experience, Living Well with Dementia, Living Well with Dementia Research, Maintaining Independence, Medicines and Healthcare Products Regulatory Authority UK, Medicines Evaluation Board Netherlands, Modifiable Risk Factors, Open Science and Data, Organisation for Economic Co-operation and Development (OECD), Organisation for Economic Cooperation and Development, Partnership and Collaboration, Partnership Working, Patient Experience, Personal Experience of Dementia, Peter Paniccia, Pharmaceutical and Medical Devices Agency Japan, Pharmaceutical Industry, Pharmaceutical Regulators, Pre-Clinical Fund, Pre-Clinical Space, Prescribed Disengagement, Prime Minister's Challenge on Dementia, Prime Minister’s Dementia Challenge, Prodromal Alzheimer's Disease, Professor Martin Rossor: Former Director of the NIHR Dementia and Neurodegenerative Disease Research Network (DeNDRoN), Professor Martin Rossor: NIHR National Director for Dementia Research, Professor Martin Rossor: UCL Institute of Neurology, Raj Long: Senior Regulatory Officer for Integrated Development in Global Health at the Bill & Melinda Gates Foundation, Reablement, Reablement Services, Regaining Independence, Rehabilitation, Rehabilitation and Self Management, Research and Innovation, Resource and Incentives, Risk Factors, Risk Factors for Alzheimer's Diseease, Risk Reduction (Formerly Termed Prevention by WDC), Science and Innovation, Service User Experience, Sir Mark Walport, Sir Mark Walport (Wellcome Trust), Specialist Rehabilitation Services, Staying Independent, Support for Carers, Sustainable Care, Tackling Barriers to Innovation, Third Global Dementia Legacy Event, Third Global Dementia Legacy Event (Japan: November 2014), Third World Dementia Council Meeting Communique, Unhealthy Behaviours, Unhealthy Lifestyles, Unhealthy Living, US Food and Drug Administration, WDC Dementia Risk Reduction Statement, WDC: World Dementia Council, World Dementia Council, World Health Organisation (WHO), World Health Organization (WHO) | Leave a comment

Tag Archives: Alzheimer’s Disease International (ADI)

Dementia Medication De-Listed in France: Untruth, Half-Truth or Paternalistic News Blackout? (BBC News / Prescrire / ADI / Inside Health / JAMA Network Open)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites